Therefore, in diabetic foot ulcers (DFUs), the activity of NRF2 (Nuclear factor erythroid 2-related factor 2) is suppressed, and the regulatory miR-27b plays a role in disrupting the NRF2-mediated angiogenesis pathway. The gene discussed is NFE2L2; the disease is diabetic foot.